Active	Status	Sponsor type	Region	Phase	Filter
18 Active 0 Inactive 18 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

11 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Comellas, Alejandro
NCT04203797 / 2019-002742-20: A Study to Evaluate the Effect of Dupilumab on Exercise Capacity in Adult Patients With Asthma	Completed	4	40	Europe, US	dupilumab, Dupixent®, SAR231893, Matching placebo	Regeneron Pharmaceuticals	Asthma	07/23	07/23
RESOLUTION, NCT04417257: Study of LAU-7b for the Treatment of COVID-19 Disease in Adults	Completed	2/3	125	Canada, US	LAU-7b, fenretinide, Placebo oral capsule	Laurent Pharmaceuticals Inc.	COVID-19 Disease	02/24	05/24
NCT04524962: Study of Descartes-30 in Acute Respiratory Distress Syndrome	Terminated	1	12	US	Descartes 30	Cartesian Therapeutics, National Heart, Lung, and Blood Institute (NHLBI)	Acute Respiratory Distress Syndrome, Covid19	09/22	09/23
NCT06311435: Utilizing Novel Blood RNA Biomarkers as a Diagnostic Tool in the Identification of Long COVID-19	Recruiting	N/A	224	US	RNA Biomarker Blood Test	MaxWell Clinic, PLC	Long COVID	03/26	03/26
Hearne, Steven
VICTORION-2P, NCT05030428: Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease	Active, not recruiting	3	17004	Europe, Canada, Japan, US, RoW	Inclisiran sodium 300 mg, Placebo	Novartis Pharmaceuticals	Atherosclerotic Cardiovascular Disease	10/27	10/27
NCT04496518: Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)	Active, not recruiting	N/A	2200	Europe, US	Intrinsic Antitachycardia Pacing (iATP) Therapy	Medtronic	Ventricular Tachycardia	01/25	01/27
NCT04489225: Personalized Therapy Study - HFRS (TriageHF) Post Approval Study	Active, not recruiting	N/A	2200	Europe, US	Observational	Medtronic	Heart Failure	01/25	01/27
ASQ, NCT04024943: Personalized Therapy Study - Attain Stability Quad Post-Approval Study	Active, not recruiting	N/A	1092	Europe, US	Quadripolar LV Lead, Medtronic CRT-P, Medtronic CRT-D	Medtronic	Heart Failure	01/27	04/27
TRIO CAP, NCT05017935: RADIANCE Continued Access Protocol	Active, not recruiting	N/A	300	US	Renal Denervation	ReCor Medical, Inc.	Hypertension, Hypertension, Resistant to Conventional Therapy, Vascular Diseases, Cardiovascular Diseases	12/28	12/28
NCT06048731: Enlighten Study: The EV-ICD Post Approval Registry	Recruiting	N/A	1000	Europe, Canada, US, RoW	Defibrillation using EV-ICD	Medtronic	Ventricular Arrhythmia, Tachycardia	05/30	10/37
Brimer, Megan
TRIO CAP, NCT05017935: RADIANCE Continued Access Protocol	Active, not recruiting	N/A	300	US	Renal Denervation	ReCor Medical, Inc.	Hypertension, Hypertension, Resistant to Conventional Therapy, Vascular Diseases, Cardiovascular Diseases	12/28	12/28